These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 29730946)
61. Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients. Ro Y; Eun CS; Kim HS; Kim JY; Byun YJ; Yoo KS; Han DS Gut Liver; 2016 Jul; 10(4):581-6. PubMed ID: 27021503 [TBL] [Abstract][Full Text] [Related]
64. Continued high use of PPIs despite C. difficile risk. Brown C CMAJ; 2014 Dec; 186(18):1350. PubMed ID: 25384647 [No Abstract] [Full Text] [Related]
65. Proton pump inhibitors and diarrhoea related to Clostridium difficile infection in hospitalised patients: a case-control study. Leonard AD; Ho KM; Flexman J Intern Med J; 2012 May; 42(5):591-4. PubMed ID: 22616966 [TBL] [Abstract][Full Text] [Related]
66. Do PPIs have long-term side effects? Nexium and the other proton-pump inhibitors are great at reducing stomach acid, but that might have some unintended consequences. Harv Health Lett; 2009 Jan; 34(3):4-5. PubMed ID: 19172761 [No Abstract] [Full Text] [Related]
68. Proton pump inhibitor therapy and osteoporosis. Yang YX Curr Drug Saf; 2008 Sep; 3(3):204-9. PubMed ID: 18691003 [TBL] [Abstract][Full Text] [Related]
69. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274 [TBL] [Abstract][Full Text] [Related]
70. SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS. Chinzon D; Domingues G; Tosetto N; Perrotti M Arq Gastroenterol; 2022; 59(2):219-225. PubMed ID: 35830032 [TBL] [Abstract][Full Text] [Related]
71. Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism. Swaminathan K Indian J Pharmacol; 2015; 47(3):330-1. PubMed ID: 26069375 [TBL] [Abstract][Full Text] [Related]
72. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor. Gordon D; Young LR; Reddy S; Bergman C; Young JD J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410 [TBL] [Abstract][Full Text] [Related]
73. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort. Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924 [TBL] [Abstract][Full Text] [Related]
74. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study. van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499 [TBL] [Abstract][Full Text] [Related]
75. Staying healthy while using PPIs. Be mindful of risks for fracture, low B12, and a spike in stomach acid. Harv Health Lett; 2015 Feb; 40(4):7. PubMed ID: 26223055 [No Abstract] [Full Text] [Related]